Aim: Although the treatment of early gastric cancer with endoscopic submucosal dissection (ESD)
has been widely carried out, a standardized method of sedation for ESD has not been …

Background/Aim: To prospectively evaluate the efficacy and safety of the BNT162b2 vaccine
in solid cancer patients undergoing systemic chemotherapy (n=63). Patients and Methods: …

Objective Recent guidelines have adopted an incidence of febrile neutropenia (FN) threshold
of 20% for the use of prophylactic granulocyte colony-stimulating factor (G-CSF). In a …

Aims: In this study, we focused on the fat ratio within psoas muscle (FRPM) and sought to
clarify the impact of FRPM on overall survival (OS) in stage IV gastric cancer (GC) patients …

… Fukutaro Shimamoto launched this research, analyzed the data, and wrote this manuscript.
Masahiro Goto and Kazuhide Higuchi provided constructive advice when writing the …

560 Background: Aprepitant (APR) showed the efficacy for the prevention of chemotherapy-induced
nausea and vomiting (CINV) with highly emetogenic chemotherapy. The …

Objective The results of KEYNOTE-164 and 158 show the efficacy of Pembrolizumab for MSI-High
solid tumors. However, the frequency of MSI-High is low, so real-world data is still …

Introduction: Previous prospective studies suggest that the sequential use of cytotoxic agents,
such as oxaliplatin, in patients with metastatic colorectal cancer (mCRC) has the potential …

274 Background: Granulocyte Colony-Stimulating Factors (GCSF) is used as supportive care
in cancer management when patients (pts) receive chemotherapy with high risk of febrile …

We present a 68 years old woman who was referred to our department due to impaired liver
function. Hepatitis A IgM antibody and anti-nuclear antibody were positive, IgG, and gamma-…